UBS names its top-conviction picks for the rest of 2023
Here are some of the stocks UBS analysts think will outperform amid an uncertain market environment. Source link
Read moreHere are some of the stocks UBS analysts think will outperform amid an uncertain market environment. Source link
Read moreCAR-T immunotherapies and antibody drug conjugates will highlight the American Society of Clinical Oncology's cancer research conference that starts Thursday.
Read moreHere are the biggest calls on Wall Street on Source link
Read moreThe authors said the estimated cost of Leqembi to Medicare are conservative, and spending on the Alzheimer's treatment may increase
Read moreHe was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of
Read moreHere are the most important news items that investors need to start their trading day. Source link
Read moreMore than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services
Read moreDr. Robert Califf says in an interview with CNBC that better regulation is needed to combat health misinformation that's costing
Read moreThe French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs
Read more